Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leyanira Torrealba

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Gut|January 11, 2025
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCUJavier P Gisbert, María G Donday, Sabino Riestra, et al.
The American Journal of Gastroenterology|December 14, 2022
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCUManuel Barreiro-de Acosta, Agnès Fernández-Clotet, Francisco Mesonero, et al.
The American Journal of Gastroenterology|January 30, 2023
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and SafetyMaría Chaparro, Diana Acosta, Cristina Rodríguez, et al.
Gastroenterologia Y Hepatologia|May 6, 2024
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohortCristina Suárez Ferrer, Francisco Mesonero Gismero, Berta Caballol, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2024
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registryRocío Ferreiro-Iglesias, Sol Porto Silva, Sandra Marín, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Gut|January 11, 2025
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCUJavier P Gisbert, María G Donday, Sabino Riestra, et al.
The American Journal of Gastroenterology|December 14, 2022
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCUManuel Barreiro-de Acosta, Agnès Fernández-Clotet, Francisco Mesonero, et al.
The American Journal of Gastroenterology|January 30, 2023
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and SafetyMaría Chaparro, Diana Acosta, Cristina Rodríguez, et al.
Gastroenterologia Y Hepatologia|May 6, 2024
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohortCristina Suárez Ferrer, Francisco Mesonero Gismero, Berta Caballol, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2024
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registryRocío Ferreiro-Iglesias, Sol Porto Silva, Sandra Marín, et al.
Pageof 2